《本地樓市》中信泰富渣甸山豪宅項目命名「峻譽-渣甸山」 涉114伙料明年首季推出
中信股份(00267.HK)旗下中信泰富公布,位於大坑道135號的豪宅發展項目正式命名為「JARDINI峻譽-渣甸山」。
項目由兩座物業組成,提供共114伙,標準分層住宅涵蓋兩房至四房戶型,實用面積約由434至1,686平方呎;另設9個連天台或平台特色戶,實用面積介乎622至2,986平方呎。
中信泰富物業代理董事李肇文表示,該項目正在申請預售樓花同意書,有望於明年首季推出,將按屆時市況採取善價而沽的推售策略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.